EIR Document: Xellia (Taizhou) Pharmaceuticals, Apr 6, 2018

Name: FDA EIR Xellia (Taizhou) Pharmaceuticals, Taizhou | April 2018
Brand: U.S. FDA
Price: 995 USD
Availability: InStock

Establishment Inspection Report for the FDA inspection at Xellia (Taizhou) Pharmaceuticals's Taizhou site on Apr 06, 2018. Get detailed insights.